Medical costs of treating venous stasis ulcers: Evidence from a retrospective cohort study

Jeffrey W. Olin, Kathleen M. Beusterien, Mary Beth Childs, Caroline Seavey, Linda McHugh, Robert I. Griffiths

Research output: Contribution to journalArticle

Abstract

Venous stasis ulcers (VSU) account for approximately 80-90% of lower extremity ulcerations. Given their prevalence and chronic nature, VSU are thought to impose a significant economic burden on Medicare (the USA's largest health insurance program) and other third party payers. However, comprehensive studies on the costs of VSU treatment are lacking. The objective of this study therefore was to examine comprehensively the direct medical costs of treating patients with a VSU in routine clinical practice. A cohort of 78 patients who presented with a VSU to the Cleveland Clinic Foundation (CCF), a large primary and tertiary referral center, was studied retrospectively. All inpatient and outpatient costs related to VSU treatment that were incurred during the year following VSU presentation or until the ulcer healed, whichever occurred first, were quantified. A total of 71 (91%) patients healed during the study. The average duration of follow-up was 119 days (median: 84 days). The average number of visits per patient was seven (range: 2 to 57). A total of 14 (18%) patients underwent 18 hospitalizations for VSU care. The average total medical cost per patient was $9685 (median: $3036). Home health care, hospitalizations and home dressing changes accounted for 48%, 25% and 21% of total costs, respectively. Total costs were related to duration of active therapy, ulcer size and the presence of at least one comorbidity (p

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalVascular Medicine
Volume4
Issue number1
StatePublished - 1999

Fingerprint

Varicose Ulcer
Cohort Studies
Retrospective Studies
Costs and Cost Analysis
Ulcer
Hospitalization
Health Insurance Reimbursement
Bandages
Health Insurance
Home Care Services
Medicare
Tertiary Care Centers
Comorbidity
Inpatients
Lower Extremity
Outpatients
Therapeutics
Economics
Delivery of Health Care

Keywords

  • Economics
  • Health care costs
  • Medical resource utilization
  • Venous stasis ulcer

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Olin, J. W., Beusterien, K. M., Childs, M. B., Seavey, C., McHugh, L., & Griffiths, R. I. (1999). Medical costs of treating venous stasis ulcers: Evidence from a retrospective cohort study. Vascular Medicine, 4(1), 1-7.

Medical costs of treating venous stasis ulcers : Evidence from a retrospective cohort study. / Olin, Jeffrey W.; Beusterien, Kathleen M.; Childs, Mary Beth; Seavey, Caroline; McHugh, Linda; Griffiths, Robert I.

In: Vascular Medicine, Vol. 4, No. 1, 1999, p. 1-7.

Research output: Contribution to journalArticle

Olin, JW, Beusterien, KM, Childs, MB, Seavey, C, McHugh, L & Griffiths, RI 1999, 'Medical costs of treating venous stasis ulcers: Evidence from a retrospective cohort study', Vascular Medicine, vol. 4, no. 1, pp. 1-7.
Olin JW, Beusterien KM, Childs MB, Seavey C, McHugh L, Griffiths RI. Medical costs of treating venous stasis ulcers: Evidence from a retrospective cohort study. Vascular Medicine. 1999;4(1):1-7.
Olin, Jeffrey W. ; Beusterien, Kathleen M. ; Childs, Mary Beth ; Seavey, Caroline ; McHugh, Linda ; Griffiths, Robert I. / Medical costs of treating venous stasis ulcers : Evidence from a retrospective cohort study. In: Vascular Medicine. 1999 ; Vol. 4, No. 1. pp. 1-7.
@article{69e1db2219504257a6333c76fde63634,
title = "Medical costs of treating venous stasis ulcers: Evidence from a retrospective cohort study",
abstract = "Venous stasis ulcers (VSU) account for approximately 80-90{\%} of lower extremity ulcerations. Given their prevalence and chronic nature, VSU are thought to impose a significant economic burden on Medicare (the USA's largest health insurance program) and other third party payers. However, comprehensive studies on the costs of VSU treatment are lacking. The objective of this study therefore was to examine comprehensively the direct medical costs of treating patients with a VSU in routine clinical practice. A cohort of 78 patients who presented with a VSU to the Cleveland Clinic Foundation (CCF), a large primary and tertiary referral center, was studied retrospectively. All inpatient and outpatient costs related to VSU treatment that were incurred during the year following VSU presentation or until the ulcer healed, whichever occurred first, were quantified. A total of 71 (91{\%}) patients healed during the study. The average duration of follow-up was 119 days (median: 84 days). The average number of visits per patient was seven (range: 2 to 57). A total of 14 (18{\%}) patients underwent 18 hospitalizations for VSU care. The average total medical cost per patient was $9685 (median: $3036). Home health care, hospitalizations and home dressing changes accounted for 48{\%}, 25{\%} and 21{\%} of total costs, respectively. Total costs were related to duration of active therapy, ulcer size and the presence of at least one comorbidity (p",
keywords = "Economics, Health care costs, Medical resource utilization, Venous stasis ulcer",
author = "Olin, {Jeffrey W.} and Beusterien, {Kathleen M.} and Childs, {Mary Beth} and Caroline Seavey and Linda McHugh and Griffiths, {Robert I.}",
year = "1999",
language = "English (US)",
volume = "4",
pages = "1--7",
journal = "Vascular Medicine",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Medical costs of treating venous stasis ulcers

T2 - Evidence from a retrospective cohort study

AU - Olin, Jeffrey W.

AU - Beusterien, Kathleen M.

AU - Childs, Mary Beth

AU - Seavey, Caroline

AU - McHugh, Linda

AU - Griffiths, Robert I.

PY - 1999

Y1 - 1999

N2 - Venous stasis ulcers (VSU) account for approximately 80-90% of lower extremity ulcerations. Given their prevalence and chronic nature, VSU are thought to impose a significant economic burden on Medicare (the USA's largest health insurance program) and other third party payers. However, comprehensive studies on the costs of VSU treatment are lacking. The objective of this study therefore was to examine comprehensively the direct medical costs of treating patients with a VSU in routine clinical practice. A cohort of 78 patients who presented with a VSU to the Cleveland Clinic Foundation (CCF), a large primary and tertiary referral center, was studied retrospectively. All inpatient and outpatient costs related to VSU treatment that were incurred during the year following VSU presentation or until the ulcer healed, whichever occurred first, were quantified. A total of 71 (91%) patients healed during the study. The average duration of follow-up was 119 days (median: 84 days). The average number of visits per patient was seven (range: 2 to 57). A total of 14 (18%) patients underwent 18 hospitalizations for VSU care. The average total medical cost per patient was $9685 (median: $3036). Home health care, hospitalizations and home dressing changes accounted for 48%, 25% and 21% of total costs, respectively. Total costs were related to duration of active therapy, ulcer size and the presence of at least one comorbidity (p

AB - Venous stasis ulcers (VSU) account for approximately 80-90% of lower extremity ulcerations. Given their prevalence and chronic nature, VSU are thought to impose a significant economic burden on Medicare (the USA's largest health insurance program) and other third party payers. However, comprehensive studies on the costs of VSU treatment are lacking. The objective of this study therefore was to examine comprehensively the direct medical costs of treating patients with a VSU in routine clinical practice. A cohort of 78 patients who presented with a VSU to the Cleveland Clinic Foundation (CCF), a large primary and tertiary referral center, was studied retrospectively. All inpatient and outpatient costs related to VSU treatment that were incurred during the year following VSU presentation or until the ulcer healed, whichever occurred first, were quantified. A total of 71 (91%) patients healed during the study. The average duration of follow-up was 119 days (median: 84 days). The average number of visits per patient was seven (range: 2 to 57). A total of 14 (18%) patients underwent 18 hospitalizations for VSU care. The average total medical cost per patient was $9685 (median: $3036). Home health care, hospitalizations and home dressing changes accounted for 48%, 25% and 21% of total costs, respectively. Total costs were related to duration of active therapy, ulcer size and the presence of at least one comorbidity (p

KW - Economics

KW - Health care costs

KW - Medical resource utilization

KW - Venous stasis ulcer

UR - http://www.scopus.com/inward/record.url?scp=0032951333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032951333&partnerID=8YFLogxK

M3 - Article

C2 - 10355863

AN - SCOPUS:0032951333

VL - 4

SP - 1

EP - 7

JO - Vascular Medicine

JF - Vascular Medicine

SN - 1358-863X

IS - 1

ER -